BASOSQUAMOUS CARCINOMA

This adverse event was reported 149 times

These drugs are most commonly taken by patients reporting BASOSQUAMOUS CARCINOMA:

# Drug Count
0 ADALIMUMAB 15
1 INFLIXIMAB 13
2 METHOTREXATE SODIUM 13
3 METHOTREXATE 11
4 LENALIDOMIDE 10
5 PREDNISONE 10
6 AMLODIPINE 9
7 TACROLIMUS 8
8 TACROLIMUS EXTENDED-RELEASE CAPSULES 8
9 TACROLIMUS OINTMENT 0.1% 8
See all common drugs associated with BASOSQUAMOUS CARCINOMA